StatLab Medical, a developer and manufacturer of pathology supplies and equipment, today announced the global launch of the CytoPath Disc, technology designed to standardize and simplify cell block preparation.
Developed as an alternative to traditional cell block methods, which convert concentrated cells suspended in fluid into a paraffin-embedded format for slide-based evaluation, the patent‑pending CytoPath Disc offers a more streamlined and efficient approach. The CytoPath Disc absorbs concentrated cells within a sponge-like matrix, which is then processed, embedded, stained, and sectioned using standard histology workflows.
Traditional cell block preparation methods often present challenges in achieving consistent results due to complex procedures, as well as the need for additional equipment or reagents. The CytoPath Discs enable labs to standardize cell block preparation, delivering reliable, reproducible samples that are proven to support accurate diagnoses in downstream IHC and molecular applications.
Designed and developed in StatLab’s Martinengo site by Diapath, the launch highlights the strength of the organization’s integrated global Research and Development capabilities. The CytoPath Disc complements StatLab’s existing portfolio of cytology essentials, including fixatives, stains, and slides, supporting effective pre-analytical sample preparation.
